The Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial virus (RSV) vaccine for use in at-risk adults over the age of 50. GSK, the vaccine’s maker, announced the approval Friday, making it the first vaccine rubber-stamped for adults ages 50-59 to protect against the virus. “Today’s approval reflects the importance…

The Hill | Healthcare News

09.06.2024

Trump takes credit for insulin pricing: Biden 'had nothing to do with it'

Former President Trump took credit for insulin pricing in a post on Truth Social Saturday.

The Hill | Healthcare News

10.06.2024

James Clyburn on Donald Trump attempt to take credit for insulin pricing: 'How can you be so bold with your lies'

Rep. James Clyburn (D-S.C.) took aim at former President Trump for trying to take credit for low prices of insulin over the weekend.

The Hill | Healthcare News

22.06.2024

Supreme Court abortion pill decision ties issue to Trump-Biden race

The Supreme Court's decision on mifepristone's future is playing into the 2024 presidential election, as anti-abortion groups plan to restrict access or remove the drug from the market.

home›The Hill | Healthcare News

The Hill | Healthcare News

Health

FDA approves first RSV vaccine for use in at-risk adults over 50

Trump takes credit for insulin pricing: Biden 'had nothing to do with it'

James Clyburn on Donald Trump attempt to take credit for insulin pricing: 'How can you be so bold with your lies'

Supreme Court abortion pill decision ties issue to Trump-Biden race

home
›
The Hill | Healthcare News